Search

everythinglearnresearchcommunity

for

Search:↓

Certain medications can cause serious side effects, so it's important to report them.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Anticancer drugs like methotrexate and trimetrexate could be effective and safe for treating malaria at low doses.

Botulinum toxin injections do not help with male pattern baldness.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

DFMO may help control hair growth and treat cancer.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

A specific RNA molecule blocks hair growth by affecting a protein related to hair loss conditions.

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.

Genotyping for NUDT15 p.Arg139Cys can help predict thiopurine side effects in Japanese IBD patients.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

New strategies like vitamin A and dextromethorphan can help reduce methotrexate side effects and improve patient adherence.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

Applying certain inhibitors to the skin can promote hair growth without harming cells.

Retinoids or their analogs could treat skin pigmentation disorders like melasma and vitiligo.

Newly made nicotinamide compounds could potentially treat cancer.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Benzothiazepines like diltiazem reduce anxiety in mice by making neurosteroids.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Most children with skin inflammation taking methotrexate had lab abnormalities, but liver issues often improved without changing the medication dose.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.